Optimized glucuronidation of dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Laura Hilton, Rachel Osborne, Amy S. Kenyon, Helen Baldock, Mark E. Bunnage, Jane Burrows, Nick Clarke, Michele Coghlan, David Entwistle, David Fairman, Neil Feeder, Kim James, Rhys M. Jones, Nadia Laouar, Graham Lunn, Stuart Marshall, Sandra D. Newman, Sheena Patel, Matthew D. Selby, Fiona Spence, Emilio F. Stuart, Susan Summerhill, Michael A. Trevethick, Karen N. Wright, Michael Yeadon, David A. Price, Lyn H. Jones
  • MedChemComm, January 2011, Royal Society of Chemistry
  • DOI: 10.1039/c1md00140j
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Lyn H Jones

In partnership with: